Volume 9 Number 1 2025
Outcomes of Total Hip Arthroplasty in Ankylosing Spondylitis Patients: A Prospective Study
Mohammad Sazzad Hossain1*, Erfanul Huq Siddiqui1, Sharif Md. Musa1, Shaik Forhad 1
Integrative Biomedical Research (Journal of Angiotherapy) 7(1) 1-8 https://doi.org/10.25163/angiotherapy.7110294
Submitted: 02 May 2023 Revised: 21 July 2023 Published: 22 July 2023
Abstract
Background: Ankylosing Spondylitis (AS) is a chronic inflammatory disease that primarily affects the axial skeleton, often leading to hip involvement and significant pain. Total Hip Arthroplasty (THA) is an effective surgical option for advanced AS, improving function and quality of life. This study aims to assess the outcomes of THA in AS patients at a tertiary care hospital in Bangladesh. Methods: A prospective observational study was conducted with 50 AS patients who underwent THA between January and December 2022. Preoperative and six-month postoperative assessments were performed using the Harris Hip Score (HHS) and Range of Motion (ROM) measurements. Data on demographics, comorbidities, disease duration, and postoperative complications were collected and analyzed using SPSS 25.0. Results: The mean age of the patients was 38.6 years, with 50% having bilateral hip involvement. The mean HHS significantly improved from 44.2 ± 12.3 preoperatively to 87.2 ± 17.4 postoperatively (p < 0.001). ROM increased from 101.4° ± 40.4° to 202.2° ± 23.5°, with 84% of patients achieving excellent outcomes. No major complications were reported during the study period. Conclusion: THA significantly enhances hip function and quality of life in AS patients, with minimal complications. This demonstrates the safety and effectiveness of THA, especially in resource-limited settings like Bangladesh.
Keywords: Ankylosing Spondylitis, Total Hip Arthroplasty, Harris Hip Score, Functional Outcome, Range of Motion.
References
Bozic, K. J., Morshed, S., Bozic, Z. M., et al. (2012). Cost-effectiveness of total hip arthroplasty in ankylosing spondylitis: An analysis of SF-6D utility values. Journal of Bone and Joint Surgery—American Volume, 94(1), 28–36.
Brandt, J., Listing, J., Haibel, H., et al. (2006). Correlation of a short form of the Bath Ankylosing Spondylitis Functional Index (BASFI) with patient global assessment in ankylosing spondylitis. Arthritis & Rheumatism, 54(2), 604–610.
Braun, J., & Sieper, J. (2007). Ankylosing spondylitis. Lancet, 369(9570), 1379–1390.
Dagfinrud, H., Kvien, T. K., & Hagen, K. B. (2005). The effect of exercise therapy on patients with ankylosing spondylitis: A systematic review of randomized controlled trials. Archives of Physical Medicine and Rehabilitation, 86(11), 2202–2212.
Dean, L., Khaliq, S., Zhang, D., et al. (2018). The global epidemiology of ankylosing spondylitis. Current Rheumatology Reports, 20(1), 1.
Eshed, I., Lidar, M., Eshed, V., et al. (2010). The ankle in spondyloarthritis. Skeletal Radiology, 39(4), 307–319.
Harris, W. H. (1969). Traumatic arthritis of the hip after dislocation and acetabular fractures: Treatment by mold arthroplasty. An end-result study of 28 cases. Journal of Bone and Joint Surgery—American Volume, 51(4), 737–755.
Jacques, P., Mielants, H., De Vos, M., et al. (2002). Histopathology of sacroiliitis and spondyloarthritis. Best Practice & Research Clinical Rheumatology, 16(2), 189–204.
Khan, M. A., & van der Linden, S. M. (1990). A new perspective on the concept of ankylosing spondylitis. Clinical Rheumatology, 9(4), 453–458.
Kim, T. W., Han, H. S., Lee, S. W., et al. (2012). Risk factors for heterotopic ossification after total hip arthroplasty in patients with ankylosing spondylitis. Journal of Arthroplasty, 27(1), 164.e1–164.e5.
Kwong, L. M., Krushell, R. J., & Murphy, S. B. (2005). Cemented versus uncemented total hip arthroplasty for patients younger than 65 years. Journal of Arthroplasty, 20(7 Suppl 3), 57–61.
Lai, K. A., Shen, W. J., Yang, C. Y., et al. (2005). Total hip arthroplasty in ankylosing spondylitis: Results and factors affecting range of motion. Journal of Bone and Joint Surgery—British Volume, 87-B(2), 147–151.
Lee, C. C., Huang, C. C., Yeh, L. R., et al. (2005). Outcomes of total hip arthroplasty for ankylosing spondylitis. Journal of Bone and Joint Surgery—American Volume, 87(11), 2435–2440.
Lee, S. C., Lim, Y. S., Kim, Y. G., et al. (2013). Long-term results of total hip arthroplasty in patients with ankylosing spondylitis. Yonsei Medical Journal, 54(3), 723–728.
Lee, Y. S., Kim, J. M., Jang, J. S., et al. (2016). Total hip arthroplasty in ankylosing spondylitis: A meta-analysis. Journal of Arthroplasty, 31(9), 1995–2002.
Maksymowych, W. P., Jhangri, G. S., Fitzgerald, A. A., et al. (2002). A six-month randomized controlled trial of etanercept (Enbrel) in ankylosing spondylitis. Arthritis & Rheumatism, 46(8), 1748–1756.
Meccariello, L., Muccioli, M., Balato, G., et al. (2023). Total hip arthroplasty in ankylosing spondylitis patients: The impact of heterotopic ossification. Journal of Functional Biomaterials, 14(2), 85.
Mielants, H., Veys, E. M., De Vos, M., et al. (1995). The evolution of gut inflammation in ankylosing spondylitis and reactive arthritis. Journal of Rheumatology, 22(2), 330–336.
O'Shea, F., Boyle, C., Salonen, D., et al. (2001). Total hip arthroplasty in ankylosing spondylitis. Journal of Rheumatology, 28(8), 1885–1888.
Poussa, M., Konni, K., Virta, S., et al. (2012). Total hip arthroplasty in ankylosing spondylitis. Acta Orthopaedica, 83(5), 497–501.
Raval, A., Pal, P., Kumar, K., et al. (2017). Clinical profile of ankylosing spondylitis patients in India: A multi-center study. Indian Journal of Rheumatology, 12(1), 15–18.
Reveille, J. D., Hirsch, R., Eskola, A., et al. (2011). Prevalence of ankylosing spondylitis in the United States: A systematic literature review. Arthritis Care & Research, 63(9), 1285–1291.
Rimi, N., Islam, M. N., Sarwar, S., et al. (2023). Clinical profile and hip involvement in ankylosing spondylitis patients in Bangladesh: A cross-sectional study. Bangladesh Medical Research Council Bulletin, 49(1), 17–23.
Sarker, M. M., Akhter, N., Mostafa, G., et al. (2022). The status of rheumatology in Bangladesh. Clinical Rheumatology, 41(7), 1979–1981.
Tang, W. M., & Chiu, K. Y. (2005). Total hip arthroplasty in patients with ankylosing spondylitis. Journal of Orthopaedic Surgery (Hong Kong), 13(2), 149–155.
Tang, W. M., Chiu, K. Y., & Ng, T. P. (2007). Total hip arthroplasty in patients with ankylosing spondylitis: Results and risk factors for complications. Journal of Arthroplasty, 22(7), 981–987.
van der Linden, S., Valkenburg, H., & Cats, A. (1984). Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for modification of the New York criteria. Arthritis & Rheumatism, 27(10), 1094–1098.
Wang, Y., Zhang, X., & Ma, R. (2016). Total hip arthroplasty in ankylosing spondylitis patients: A retrospective cohort study. Journal of Arthroplasty, 31(10), 2253–2257.
Ward, M. M. (2005). Health-related quality of life in ankylosing spondylitis. Rheumatic Disease Clinics of North America, 31(2), 339–354.
Zochling, J., van der Heijde, D., & Braun, J. (2006). Assessment of ankylosing spondylitis activity and outcome. Best Practice & Research Clinical Rheumatology, 20(3), 477–492.
View Dimensions
View Altmetric
Save
Citation
View
Share